Stockholm - Free Realtime Quote SEK
Isofol Medical AB (publ) (ISOFOL.ST)
1.3820
-0.0180
(-1.29%)
As of 12:13:19 PM GMT+2. Market Open.
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
721
12,797
22,407
Operating Expense
43,635
47,209
42,405
180,340
226,872
Operating Income
-43,635
-47,209
-41,684
-167,543
-204,465
Net Non Operating Interest Income Expense
4,323
3,721
4,612
147
-163
Pretax Income
-39,270
-43,488
-37,071
-159,793
-200,251
Tax Provision
0
0
0
0
0
Net Income Common Stockholders
-39,270
-43,488
-37,071
-159,793
-200,251
Diluted NI Available to Com Stockholders
-39,270
-43,488
-37,071
-159,793
-200,251
Basic EPS
-0.27
-0.27
-0.23
-0.99
-1.59
Diluted EPS
-0.27
-0.27
-0.23
-0.99
-1.59
Basic Average Shares
161,066.6670
161,066.6670
161,178.2610
161,515.4400
125,645.1640
Diluted Average Shares
161,066.6670
161,066.6670
161,178.2610
161,515.4400
125,645.1640
Total Operating Income as Reported
-43,633
-47,209
-41,683
-167,543
-204,465
Total Expenses
43,635
47,209
42,405
180,340
226,872
Net Income from Continuing & Discontinued Operation
-39,270
-43,488
-37,071
-159,793
-200,251
Normalized Income
-39,270
-43,488
-37,071
-163,605
-203,786
Interest Income
4,323
3,721
4,622
147
5
Interest Expense
0
0
10
0
168
Net Interest Income
4,323
3,721
4,612
147
-163
EBIT
-39,270
-43,488
-37,061
-159,793
-200,083
EBITDA
-39,266
-43,485
-37,024
-159,726
-198,487
Reconciled Depreciation
4
3
37
67
1,596
Net Income from Continuing Operation Net Minority Interest
-39,270
-43,488
-37,071
-159,793
-200,251
Total Unusual Items Excluding Goodwill
0
--
0
3,812
3,535
Total Unusual Items
0
--
0
3,812
3,535
Normalized EBITDA
-39,266
-43,485
-37,024
-163,538
-202,022
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 4/4/2017
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
VICO.ST Vicore Pharma Holding AB (publ)
7.98
-1.12%
2CUREX.ST 2cureX AB (publ)
2.0600
+3.78%
EGTX.ST Egetis Therapeutics AB (publ)
3.5200
-3.56%
ATORX.ST Alligator Bioscience AB (publ)
3.9900
+2.47%
BIOVIC-B.ST Biovica International AB (publ)
0.9180
+19.53%
DBP-B.ST Double Bond Pharmaceutical Int.
0.3300
-2.08%
7XB.F Xbrane Biopharma AB
0.0177
-15.71%
QUIA.ST Quia Pharma AB (publ)
0.0075
-10.71%
APTA.ST Aptahem AB (publ)
0.8980
+5.65%
NANECH.ST NanoEcho AB
0.1078
-2.71%